BioSmart Co.Ltd (038460) — Cash Flow Quality Index
BioSmart Co.Ltd (038460) has a Cash Flow Quality Index of 1.89x as of September 2025. Operating cash flow of ₩7.59 Billion exceeds net income of ₩4.01 Billion, indicating high earnings quality where cash backs reported profits. Explore 038460 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioSmart Co.Ltd Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for BioSmart Co.Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BioSmart Co.Ltd (038460) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BioSmart Co.Ltd (2012–2024)
Year-by-year earnings quality comparison for BioSmart Co.Ltd. For live market cap and the full company financial profile, see market value of BioSmart Co.Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.60x | ₩3.80 Billion | ₩1.06 Billion | ▲ +4896.1% |
| 2023 | 0.07x | ₩1.17 Billion | ₩16.18 Billion | ▼ -99.1% |
| 2022 | 7.75x | ₩5.59 Billion | ₩721.31 Million | ▲ +796.9% |
| 2021 | 0.86x | ₩1.20 Billion | ₩1.39 Billion | ▲ +1141.6% |
| 2019 | -0.08x | ₩-1.84 Billion | ₩22.15 Billion | ▼ -107.3% |
| 2018 | 1.13x | ₩5.81 Billion | ₩5.14 Billion | ▲ +410.9% |
| 2017 | -0.36x | ₩-1.76 Billion | ₩4.83 Billion | ▼ -62.2% |
| 2015 | -0.22x | ₩-509.17 Million | ₩2.27 Billion | ▼ -112.8% |
| 2014 | 1.76x | ₩1.31 Billion | ₩743.14 Million | ▲ +80.7% |
| 2013 | 0.97x | ₩3.85 Billion | ₩3.96 Billion | ▼ -67.8% |
| 2012 | 3.02x | ₩8.62 Billion | ₩2.86 Billion | — |